Keyword: GlaxoSmithKline (GSK)

News

Eisai Pulls Fycompa from German Market after Pricing Tiff

26.06.2013 - Japanese drugmaker Eisai is to stop selling its new epilepsy therapy Fycompa in Germany - the biggest market for the product - following a row over the price it can charge for the...

News

Sanofi’s Chris Viehbacher: EU’s Drug Data Stance Threatens Investment

25.06.2013 - The European Medicines Agency's (EMA) decision to release detailed data on drugs once a medicine is approved could discourage critical investment in crisis-hit Europe, Sanofi's...

News

Getting The Pulse

25.06.2013 - The Lion City - The Merlion - a mythical creature with the head of a lion and the body of a fish - is regarded as the Singapore icon ("Singapura" means "lion city" in Sanskrit). As...

News

Pfizer, GSK, and Siemens form R&D Consortium

21.06.2013 - Pfizer Asia Pacific, Glaxo Wellcome Manufacturing and Siemens have signed on as founding members of a new A*STAR R&D Consortium Programm - Innovative Processing of Specialties and...

News

Royalty Drops Hostile Bid For Ireland's Elan

19.06.2013 - U.S.-based Royalty Pharma has dropped a hostile bid worth up to $8 billion for Elan, leaving the Irish drugmaker free to seek other suitors having put itself up for sale last week...

News

FDA Panel Votes to Relax Avandia Restrictions

07.06.2013 - U.S. health advisers voted on Thursday to recommend relaxing market restrictions on GlaxoSmithKline's diabetes drug Avandia, the former blockbuster at the center of one of the...

News

Ruling Threatens Royalty's Elan Bid Ahead of Key Meeting

07.06.2013 - Royalty Pharma received a blow in its battle to take over Irish drug firm Elan on Thursday after a ruling on conditions attached to the U.S. company's hostile bid threatened to...

News

GSK Bets on Chimp Virus with $321 Million Vaccines Buy

29.05.2013 - GlaxoSmithKline is betting on a new vaccine technology based on chimpanzee viruses by acquiring Swiss-based Okairos for €250 million ($321 million) - the latest bolt-on biotech buy...